CMAC is an internationally leading manufacturing research centre with a unique configuration of academic research, applied, and pre-competitive programmes. Working in partnership with Tier 1, Tier 2, academic, and innovation partners, CMAC's goal is to transform Medicines Development, Manufacture & Supply, and further grow its world-class portfolio of multi-disciplinary collaborative research. This includes the Digital Medicines Manufacturing Research Centre (DM²), Digital Design and Manufacture of Amorphous Pharmaceuticals (DDMAP), UKRPIF Net Zero Pilot, UKRPIF CMAC Data Lab, and the CMAC Future Manufacturing Research Hub, along with training and translation projects within a world-class facility. The CMAC National Facility provides contract research services to support industries through the delivery of projects within crystallisation (batch & continuous), process development, formulation, product/process analysis and advanced materials characterisation.
Looking for a particular CMAC employee's phone or email?
The CMAC annual revenue was $12.5 million in 2026.
Massimo Bresciani is the Industry Director of CMAC.
67 people are employed at CMAC.
The NAICS codes for CMAC are [61131, 611, 6113, 61, 611310].
The SIC codes for CMAC are [822, 82].